 Quick Find
 |
|
GA Applications
|
| |
|
|
|
 Imagine being able to multiplex up to 40 genes in one reaction, quantitatively and reproducibly, using only a small amount of your precious RNA sample. Imagine no longer! You can now achieve this with our patented, highly multiplexed reverse transcription PCR* approach (XP-PCR*) to quickly and efficiently look at the expression of multiplexed gene sets with greater sensitivity, speed and cost effectiveness compared to singlet and multiplex based-q PCR* approaches.
The GenomeLab™ GeXP Genetic Analysis System can accurately detect as low as 0.5-fold changes in gene expression, providing more precise information than ever before. Powered with our unique universal priming strategy, XP-PCR* allows multiple reference genes, genes of interest and an internal control to be unbiasedly analyzed in a single well. This enables the most accurate normalization and leads to reliable detection of very small changes in gene expression.
The GenomeLab™ GeXP Genetic Analysis System is ideal for panel validation and pathway studies. It supports researchers who have completed their initial discovery work from the literature or large-scale screening technologies. Users can define their targets or use commercially available multiplexes from Beckman Coulter for gene expression analysis. The GeXP system is used for multiplexed, quantitative gene expression analysis as well as a multipurpose genetic analysis platform.
|
| Additional Information |
|
|
*All trademarks are the property of their respective owners. Where applicable, the PCR process is covered by patents owned by Roche Molecular Systems, Inc., and F. Hoffmann-LaRoche, Ltd.
For Laboratory Use Only; not for use in diagnostic procedures. |
|
